Aug 10 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:) -
* Valeant - John Paulson says sales of co's shares are due to rebalancing of portfolios
* Valeant - John Paulson says "continue to remain fully supportive of valeant leadership team"